Erschienen in:
14.08.2019
The metabolic syndrome in heart failure: insights to specific mechanisms
verfasst von:
Paola Gargiulo, Fabio Marsico, Francesco Renga, Simona Dell’Aversana, Immacolata Esposito, Caterina Marciano, Santo Dellegrottaglie, Pasquale Perrone-Filardi, Stefania Paolillo
Erschienen in:
Heart Failure Reviews
|
Ausgabe 1/2020
Einloggen, um Zugang zu erhalten
Abstract
The presence of comorbidities significantly influences long-term morbidity and mortality of symptomatic and asymptomatic heart failure (HF) patients. Metabolic syndrome and diabetic cardiomyopathy are two clinical conditions that share multiple pathophysiological mechanisms and that might be both responsible for cardiac dysfunction. However, it is argued whether metabolic syndrome (MS) independently increases HF risk or the association between MS and HF merely reflects the impact of individual risk factors included in its definition on HF development. Similarly, in the context of diabetic cardiomyopathy, many aspects are still challenging starting from the definition up to the therapeutic management. In this clinical review, we focused the attention on molecular pathways, myocyte alterations, and specific patterns of metabolic syndrome and diabetic cardiomyopathy in order to better define the potential diagnostic and therapeutic approaches of these two pathological conditions.